Pacific Biosciences of California (PACB) - Company Short-Term Debts

Corporate company logo of Pacific Biosciences of California, Inc. (PACB)

Pacific Biosciences (PACB) develops cutting-edge genome sequencing tools, generating profit through the sale of high-margin reagents for its installations. Financial data visualization on GURU.Markets shows that the separate_debt_short metric stands at 0.00. Revenue growth prospects now depend on the market launch of new sequencing systems, which will help overcome the current slump in research sector investment.

PACB (pacb.com) Company Current Liabilities history from 07/04/2022 to 10/30/2026

Comprehensive metric breakdowns and analytics for PacBio Corp (PACB)

- current quotes and average value forecast:
Price Chart PacBio|PACB - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization Pacific Biosciences of California, Inc.|PACB - Enterprise Value
- business book valuation details:
Book Value per Share PacBio|PACB - Company Net Assets|Market Capitalization to Book Value Ratio pacb.com|PACB - Company Total Asset Base
- debt level and financial liquidity data:
Total Debt to Capital Pacific Biosciences|PACB - Long-Term Liabilities to Equity|Short-Term Debt to Capital Pacific Biosciences|PACB - Company Total Debt Obligations|Debts to Book Capitalization Pacific Biosciences of California, Inc.|PACB - Company Long-Term Liabilities|Company Current Liabilities PacBio|Quick Ratio pacb.com
- net income and valuation multiples indicators:
PACB - Company Net Income
Fundamental company analysis:PacBio (PACB)
Manufactured products of PacBio Corp

Diversification of DNA sequencing markets requires Pacific Biosciences (PACB) to maintain flexible liquidity management. This indicator aggregates all credit obligations with maturities of up to twelve months. By analyzing current borrowings, an investor assesses the risk of cash flow deficits. The metric reflects the company's ability to service debt during periods of corporate news. This determines the issuer's financial stability while scaling technologies.

Competitor analysis

TEM - Company Short-Term Debt|Current Liabilities QGEN|IONS: Company Short-Term Debts|Repligen Inc. (RGEN) - Company Short-Term Debts|RNA (Avidity Biosciences) - Company Short-Term Debts|Company Current Liabilities crisprtx.com (CRSP)|Company Short-Term Debts WGS|Short-Term Debt Volume Ultragenyx Pharmaceutical Inc.|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|SRPT (Sarepta Corp) - Current Liabilities|Twist Bioscience - Company Short-Term Debts|Short-Term Debt Volume 10xgenomics.com TXG|NTLA: Company Short-Term Debts|Company Current Liabilities Stoke Therapeutics Inc|Company Current Liabilities BLFS|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|Company Short-Term Debt SION (sionnatx.com)|Company Short-Term Debts PRME (Prime Medicine)|Short-Term Debt Volume Taysha Gene Therapies Inc (TSHA)|QURE - Company Short-Term Debt|Short-Term Debt MeiraGTx Corp|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|SLDB - Short-Term Debt Volume|OCGN (Ocugen) - Company Short-Term Debts|Company Current Liabilities Benitec Biopharma Inc (BNTC)|Company Short-Term Debts DSGN|Short-Term Debt Volume Rocket Corp|Company Short-Term Debts FDMT (4D Molecular Therapeutics)|Lexeo Therapeutics Inc. (LXEO) - Short-Term Debt|KRRO - Company Short-Term Debt|EDIT (Editas Medicine Inc) - Company Short-Term Indebtedness|SLN: Company Short-Term Debts|Company Current Liabilities ProQR Therapeutics|CDXS (Codexis Inc) - Company Short-Term Debts|Short-Term Debt sangamo.com SGMO|Company Short-Term Debt Nautilus Biotechnology (NAUT)|Short-Term Debt Volume Metagenomi Inc.|Company Short-Term Debt Precision BioSciences DTIL|GBIO (Generation Bio Co) - Current Liabilities|Boundless Bio, Inc. - Company Short-Term Debts|XCUR - Company Short-Term Debts|IMNN: Company Short-Term Debts|Company Current Liabilities Phio Pharmaceuticals Corp.|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Company Short-Term Debt RNAZ|Company Short-Term Debts BNGO|adnas.com - Company Short-Term Indebtedness|Company Short-Term Debt bluebird bio BLUE|IPA: Company Short-Term Indebtedness|Omega - Company Short-Term Debts|OMIC - Company Short-Term Debts|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Current Liabilities SYRS (syros.com)|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Short-Term Debts UBX